![](/img/cover-not-exists.png)
Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study
Shimon Slavin, Aliza Ackerstein, Reuven Or, Michael Y. Shapira, Benjamin Gesundheit, Nadir Askenasy, Shoshana MoreckiVolume:
59
Language:
english
Pages:
9
DOI:
10.1007/s00262-010-0878-1
Date:
October, 2010
File:
PDF, 287 KB
english, 2010